Disclosures for "Effectiveness of AbobotulinumtoxinA in Adults with Lower Limb Spasticity: Top Line Results from the AboLiSh Observational Study"
-
Dr. Esquenazi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen and Allergan. Dr. Esquenazi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen and Allergan. The institution of Dr. Esquenazi has received research support from Ipsen, Allergan and Merz.
-
Richard Zorowitz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SPR Therapeutics. Richard Zorowitz has received publishing royalties from a publication relating to health care.
-
Stephen Ashford has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Stephen Ashford has received personal compensation in the range of $0-$499 for serving as a Consultant for Mertz. Stephen Ashford has received personal compensation in the range of $0-$499 for serving as a Consultant for Nutricia. The institution of Stephen Ashford has received research support from Ipsen.
-
-
Pascal Maisonobe has received personal compensation for serving as an employee of ipsen pharma.
-
Dr. Hannes has received personal compensation for serving as an employee of Ipsen. Dr. Hannes has stock in Ipsen.
-
Jorge Jacinto has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz, Ipsen, Allergan. Jorge Jacinto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merz, Allergan, Ipsen.